Immunocore
Immunocore's Overview
Immunocore is a pioneering, commercial-stage biotechnology company leading the charge in the development of a novel class of TCR (T cell receptor) bispecific immunotherapies called ImmTACs (Immune mobilizing monoclonal TCRs Against Cancer). These are designed to treat a broad range of diseases, including cancer, infectious diseases, and autoimmune conditions. Immunocore's vision is to become a premier, fully integrated biotechnology company delivering transformative medicines to patients, with its first approved product being KIMMTRAK® (tebentafusp-tebn) for uveal melanoma.
Where is Immunocore's Headquarters?
HQ Function
Serves as the central hub for global operations, including leadership, research and development, corporate functions, and strategic decision-making.
Notable Features:
Modern, purpose-built laboratory and office facilities designed to foster cutting-edge research and collaboration. Milton Park provides a dynamic campus environment with extensive amenities and networking opportunities within the biotech community.
Work Culture:
A science-driven, collaborative, and patient-focused environment. Immunocore emphasizes innovation, integrity, and teamwork, attracting a diverse and highly skilled workforce dedicated to advancing novel therapies.
HQ Significance:
The UK headquarters leverages the rich scientific talent pool and world-class academic institutions of the Oxford area, a global hub for biomedical research and innovation, enabling close collaborations and access to expertise.
Values Reflected in HQ: The headquarters' design and location reflect Immunocore's commitment to scientific excellence, innovation, sustainability, and providing an inspiring work environment for its employees.
Location:
Immunocore manages its global operations through its main headquarters in the UK and significant offices in the USA. These hubs support worldwide research collaborations, multi-national clinical trials, engagement with global regulatory bodies (such as the FDA and EMA), and the commercialization of its therapies in approved markets across North America, Europe, and other regions.
Street Address:
92 Park Drive, Milton Park
City:
Abingdon
State/Province:
Oxfordshire
Country:
United Kingdom
Immunocore's Global Presence
Conshohocken, Pennsylvania, USA
Address: Six Tower Bridge, 181 Washington Street, Suite 400, Conshohocken, PA 19428
To lead the commercialization strategy and sales of approved therapies like KIMMTRAK in the United States, manage U.S.-based clinical trials, and engage with U.S. regulatory authorities such as the FDA.
Rockville, Maryland, USA
Address: 9400 Key West Avenue, Rockville, MD 20850
To advance Immunocore's pipeline of TCR bispecific immunotherapies through dedicated research efforts, support U.S.-based discovery and clinical programs, and foster scientific collaborations.
Buying Intent Signals for Immunocore
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Immunocore
As of April 2025, Immunocore' leadership includes:
Investors of Immunocore
Immunocore has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past 12 months (mid-May 2023 to mid-May 2024), Immunocore has strengthened its leadership team with key appointments in regulatory, legal, and HR functions, supporting its growth and pipeline advancement. There was also a notable departure from a commercial leadership role.
Departures
New Appointments:
Technology (Tech Stack) used by Immunocore
Discover the tools Immunocore uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Immunocore Email Formats and Examples
Immunocore commonly uses the 'firstname.lastname@immunocore.com' email format for its employees. While this is the predominant structure, other formats might exist in specific cases or for certain departments.
firstname.lastname@immunocore.com
Format
jane.doe@immunocore.com
Example
85%
Success rate
News and media
immunocore.com (Press Release) • May 9, 2024
Immunocore Reports First Quarter 2024 Financial Results and Provides Business Update
Immunocore announced its Q1 2024 financial results, highlighting KIMMTRAK net revenues of $70.3 million, a 46% increase year-over-year. The company also provided updates on its PRAME and MAGE-A4 clinical programs, noting enrollment progress and upcoming data readouts....more
immunocore.com (Press Release) • April 10, 2024
Immunocore to Present New KIMMTRAK® (tebentafusp-tebn) Uveal Melanoma Survival Data and PRAME ImmTAC Clinical Trial Design at ASCO 2024
Immunocore announced upcoming presentations at the 2024 ASCO Annual Meeting, including new four-year overall survival data for KIMMTRAK in metastatic uveal melanoma and details on the Phase 1/2 clinical trial design for its PRAME targeting ImmTAC candidate, IMC-F106C....more
immunocore.com (Press Release) • February 28, 2024
Immunocore Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Immunocore reported its financial results for Q4 and full year 2023, with KIMMTRAK net revenues reaching $238.7 million for the full year. The company outlined its strategic priorities for 2024, emphasizing KIMMTRAK commercial expansion and advancing its pipeline of novel TCR therapies....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Immunocore, are just a search away.